Кавтеладзе З.А.

ФГБНУ «Российский научный центр хирургии имени академика Б.В. Петровского» Минобрнауки России

Ермолаев П.М.

ФГБНУ «Российский научный центр хирургии имени академика Б.В. Петровского» Минобрнауки России

Даниленко С.Ю.

ФГБНУ «Российский научный центр хирургии имени академика Б.В. Петровского» Минобрнауки России

Надарая В.М.

ФГБНУ «Российский научный центр хирургии имени академика Б.В. Петровского» Минобрнауки России

Церебральная защита при транскатетерной имплантации аортального клапана

Авторы:

Кавтеладзе З.А., Ермолаев П.М., Даниленко С.Ю., Надарая В.М.

Подробнее об авторах

Прочитано: 1060 раз


Как цитировать:

Кавтеладзе З.А., Ермолаев П.М., Даниленко С.Ю., Надарая В.М. Церебральная защита при транскатетерной имплантации аортального клапана. Хирургия. Журнал им. Н.И. Пирогова. 2024;(12‑2):150‑158.
Kavteladze ZA, Ermolaev PM, Danilenko SYu, Nadaraya VM. Cerebral protection in transcatheter aortic valve implantation. Pirogov Russian Journal of Surgery. 2024;(12‑2):150‑158. (In Russ.)
https://doi.org/10.17116/hirurgia2024122150

Рекомендуем статьи по данной теме:

Литература / References:

  1. Rouleau SG, Brady WJ, Koyfman A, Long B. Transcatheter aortic valve replacement complications: A narrative review for emergency clinicians. American Journal of Emergency Medicine. 2022;56:77-86.  https://doi.org/10.1016/j.ajem.2022.03.042
  2. Borer JS, Herrold EM, Carter JN, Catanzaro DF, Supino PG. Cellular and molecular basis of remodeling in valvular heart desease. Heart Failure Clinics. 2006;2(4):415-4424. https://doi.org/10.1016/j.hfc.2007.02.001
  3. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW, Tornos P, Vanoverschelde JL, Vermeer F, Boersma E, Ravaud P, Vahanian A. A prospective survey of patients with valvular heart disease in Europe. European Heart Journal. 2003;24(13):1231-1243. https://doi.org/10.1016/s0195-668x(03)00201-x
  4. Coffey S, Roberts-Thomson R, Brown A, Carapetis J, Chen M, Enriquez-Sarano M, Zühlke L, Prendergast BD. Global epidemiology of valvular heart disease. Nature Reviews Cardiology. 2021;18(12):853-864.  https://doi.org/10.1038/s41569-021-00570-z
  5. Thaden JJ, Nkomo VT, EnriquezSarano M. The global burden of aortic stenosis. Progress in Cardiovascular Diseases. 2014;56(6):565-571.  https://doi.org/10.1016/j.pcad.2014.02.006
  6. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jiménez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135(10):146-603.  https://doi.org/10.1161/CIR.0000000000000485
  7. Martín M, Cuevas J, Cigarrán H, Calvo J, Morís C. Transcatheter aortic valve implantation and subclinical and clinical leaflet thrombosis:multimodality imaging for diagnosis and risk stratification. European Cardiology. 2021;16:e35.  https://doi.org/10.15420/ecr.2021.09
  8. Writing Group Members; Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jiménez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB; American Heart Association Statistics Committee; Stroke Statistics Subcommittee. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation. 2016;133(4):e38-360.  https://doi.org/10.1161/CIR.0000000000000350
  9. Eveborn GW, Schirmer H, Heggelund G, Lunde P, Rasmussen K. The evolving epidemiology of valvular aortic stenosis. the Tromsø study. Heart. 2013;99(6):396-400.  https://doi.org/10.1136/heartjnl-2012-302265
  10. Vandvik PO, Otto CM, Siemieniuk RA, Bagur R, Guyatt GH, Lytvyn L, Whitlock R, Vartdal T, Brieger D, Aertgeerts B, Price S, Foroutan F, Shapiro M, Mertz R, Spencer FA. Transcatheter or surgical aortic valve replacement for patients with severe, symptomatic, aortic stenosis at lowto intermediate surgical risk: a clinical practice guideline. BMJ. 2016;354:i5085. https://doi.org/10.1136/bmj.i5085
  11. Carroll JD, Mack MJ, Vemulapalli S, Herrmann HC, Gleason TG, Hanzel G, Deeb GM, Thourani VH, Cohen DJ, Desai N, Kirtane AJ, Fitzgerald S, Michaels J, Krohn C, Masoudi FA, Brindis RG, Bavaria JE. STS-ACC TVT registry of Transcatheter aortic valve replacement. Journal of the American College of Cardiology. 2020;76(21):2492-516.  https://doi.org/10.1016/j.jacc.2020.09.595
  12. Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, O’Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A, Toly C. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. Circulation. 2021;143:e72-227.  https://doi.org/10.1161/CIR.0000000000000923
  13. Coylewright M, Forrest JK, McCabe JM, Nazif TM. TAVR in low-risk patients: FDA approval, the new NCD, and shared decision-making. Journal of the American College of Cardiology. 2020;75(10):1208-1211. https://doi.org/10.1016/j.jacc.2019.12.057
  14. Winter MP, Bartko P, Hofer F, Zbiral M, Burger A, Ghanim B, Kastner J, Lang IM, Mascherbauer J, Hengstenberg C, Goliasch G. Evolution of outcome and complications in TAVR: a meta-analysis of observational and randomized studies. Scientific Reports. 2020;10(1):155-168.  https://doi.org/10.1038/s41598-020-72453-1
  15. Osnabrugge RL, Mylotte D, Head SJ, Van Mieghem NM, Nkomo VT, LeReun CM, Bogers AJ, Piazza N, Kappetein AP. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. Journal of the American College of Cardiology. 2013;62(11):1002-1012. https://doi.org/10.1016/j.jacc.2013.05.015
  16. Алекян Б.Г., Григорьян А.М., Стаферов А.В., Карапетян Н.Г. Рентгенэндоваскулярная диагностика и лечение заболеваний сердца и сосудов в Российской Федерации — 2021 год. Эндоваскулярная хирургия. 2022;9 (Специальный выпуск):S5-S254. https://doi.org/10.24183/2409-4080-2022-9S-S5-S254
  17. Dasi LP, Hatoum H, Kheradvar A, Zareian R, Alavi SH, Sun W, Martin C, Pham T, Wang Q, Midha PA, Raghav V, Yoganathan AP. On the mechanics of transcatheter aortic valve replacement. Annals of Biomedical Engineering. 2017;45(2):310-331.  https://doi.org/10.1007/s10439-016-1759-3
  18. Kapadia SR, Kodali S, Makkar R, Mehran R, Lazar RM, Zivadinov R, Dwyer MG, Jilaihawi H, Virmani R, Anwaruddin S, Thourani VH, Nazif T, Mangner N, Woitek F, Krishnaswamy A, Mick S, Chakravarty T, Nakamura M, McCabe JM, Satler L, Zajarias A, Szeto WY, Svensson L, Alu MC, White RM, Kraemer C, Parhizgar A, Leon MB, Linke A; SENTINEL Trial Investigators. Protection against cerebral embolism during transcatheter aortic valve replacement. Journal of the American College of Cardiology. 2017;69:367-77.  https://doi.org/10.1016/j.jacc.2016.10.023
  19. Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-Expanding valve in low-risk patients. New England Journal of Medicine. 2019;380(18):1706-1715. https://doi.org/10.1056/NEJMoa1816885
  20. Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, Kapadia SR, Malaisrie SC, Cohen DJ, Pibarot P, Leipsic J, Hahn RT, Blanke P, Williams MR, McCabe JM, Brown DL, Babaliaros V, Goldman S, Szeto WY, Genereux P, Pershad A, Pocock SJ, Alu MC, Webb JG, Smith CR; PARTNER 3 Investigators. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. New England Journal of Medicine. 2019;380(18):1695-1705. https://doi.org/10.1056/NEJMoa1814052
  21. Iskander M, Jamil Y, Forrest JK, Madhavan MV, Makkar R, Leon MB, Lansky A, Ahmad Y. Cerebral Embolic Protection in Transcatheter Aortic Valve Replacement. Review Article. Structural Heart. 2023;7(4):100169. https://doi.org/10.1016/j.shj.2023.100169
  22. Ten Berg J, Sibbing D, Rocca B, Van Belle E, Chevalier B, Collet JP, Dudek D, Gilard M, Gorog DA, Grapsa J, Grove EL, Lancellotti P, Petronio AS, Rubboli A, Torracca L, Vilahur G, Witkowski A, Mehilli J. Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart Disease. European Heart Journal. 2021;42(23):2265-2269. https://doi.org/10.1093/eurheartj/ehab196
  23. Agrawal A, Isogai T, Shekhar S, Kapadia S. Cerebral Embolic Protection Devices: Current State of the Art. US Cardiology. 2023;17;e02.  https://doi.org/10.15420/usc.2022.12
  24. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. New England Journal of Medicine. 2010;363(17):1597-1607. https://doi.org/10.1056/NEJMoa1008232
  25. Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Buchbinder M, Hermiller JJ, Kleiman NS, Chetcuti S, Heiser J, Merhi W, Zorn G, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Conte J, Maini B, Mumtaz M, Chenoweth S, Oh JK. Transcatheter aortic-valve replacement with a self-expanding prosthesis. New England Journal of Medicine. 2014;370(19):1790-1798. https://doi.org/10.1056/NEJMoa1400590
  26. Auffret V, Lefevre T, Van Belle E, Eltchaninoff H, Iung B, Koning R, Motreff P, Leprince P, Verhoye JP, Manigold T, Souteyrand G, Boulmier D, Joly P, Pinaud F, Himbert D, Collet JP, Rioufol G, Ghostine S, Bar O, Dibie A, Champagnac D, Leroux L, Collet F, Teiger E, Darremont O, Folliguet T, Leclercq F, Lhermusier T, Olhmann P, Huret B, Lorgis L, Drogoul L, Bertrand B, Spaulding C, Quilliet L, Cuisset T, Delomez M, Beygui F, Claudel JP, Hepp A, Jegou A, Gommeaux A, Mirode A, Christiaens L, Christophe C, Cassat C, Metz D, Mangin L, Isaaz K, Jacquemin L, Guyon P, Pouillot C, Makowski S, Bataille V, Rodés-Cabau J, Gilard M, Le Breton H; FRANCE TAVI Investigators. Temporal trends in transcatheter aortic valve replacement in France: FRANCE 2 to FRANCE TAVI. Journal of the American College of Cardiology. 2017;70:42-55.  https://doi.org/10.1016/j.jacc.2017.04.053
  27. Kapadia S, Agarwal S, Miller DC, Webb JG, Mack M, Ellis S, Herrmann HC, Pichard AD, Tuzcu EM, Svensson LG, Smith CR, Rajeswaran J, Ehrlinger J, Kodali S, Makkar R, Thourani VH, Blackstone EH, Leon MB. Insights into timing, risk factors, and outcomes of stroke and transient ischemic attack after transcatheter aortic valve replacement in the PARTNER trial (placement of aortic transcatheter valves). Circulation. Cardiovascular Interventions. 2016;9(9):e002981. https://doi.org/10.1161/CIRCINTERVENTIONS.115.002981
  28. Huded CP, Tuzcu EM, Krishnaswamy A, Mick SL, Kleiman NS, Svensson LG, Carroll J, Thourani VH, Kirtane AJ, Manandhar P, Kosinski AS, Vemulapalli S, Kapadia SR. Association between transcatheter aortic valve replacement and early postprocedural stroke. JAMA. 2019;321(23):2306-2315. https://doi.org/10.1001/jama.2019.7525
  29. Vlastra W, Jimenez-Quevedo P, Tchétché D, Chandrasekhar J, de Brito FS Jr, Barbanti M, Kornowski R, Latib A, D’Onofrio A, Ribichini F, Baan J, Tijssen JGP, De la Torre Hernandez JM, Dumonteil N, Sarmento-Leite R, Sartori S, Rosato S, Tarantini G, Lunardi M, Orvin K, Pagnesi M, Hernandez-Antolin R, Modine T, Dangas G, Mehran R, Piek JJ, Delewi R. Predictors, incidence, and outcomes of patients undergoing transfemoral transcatheter aortic valve implantation complicated by stroke. Circulation. Cardiovascular Interventions. 2019;12(3):e007546. https://doi.org/10.1161/CIRCINTERVENTIONS.118.007546
  30. Muralidharan A, Thiagarajan K, Van Ham R, Gleason TG, Mulukutla S, Schindler JT, Jeevanantham V, Thirumala PD. Meta-analysis of perioperative stroke and mortality in transcatheter aortic valve implantation. American Journal of Cardiology. 2016;118(7):1031-1045. https://doi.org/10.1016/j.amjcard.2016.07.011
  31. Jimenez Diaz VA, Kapadia SR, Linke A, Mylotte D, Lansky AJ, Grube E, Settergren M, Puri R. Cerebral embolic protection during transcatheter heart interventions. EuroIntervention. 2023;18;19(7):549-570.  https://doi.org/10.4244/EIJ-D-23-00166
  32. Kahlert P, Al-Rashid F, Döttger P, Mori K, Plicht B, Wendt D, Bergmann L, Kottenberg E, Schlamann M, Mummel P, Holle D, Thielmann M, Jakob HG, Konorza T, Heusch G, Erbel R, Eggebrecht H. Cerebral embolization during transcatheter aortic valve implantation: a transcranial Doppler study. Circulation. 2012;126(10):1245-1255. https://doi.org/10.1161/CIRCULATIONAHA.112.092544
  33. Makkar RR, Fontana G, Sondergaard L. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. New England Journal of Medicine. 2016;374(16):1591-1592. https://doi.org/10.1056/NEJMc1600179
  34. Jorgensen TH, Thyregod HG, Tarp JB, Svendsen JH, Sondergaard L. Temporal changes of new-onset atrial fibrillation in patients randomized to surgical or transcatheter aortic valve replacement. International Journal of Cardiology. 2017;234:16-21. 
  35. Kleiman NS, Maini BJ, Reardon MJ, Conte J, Katz S, Rajagopal V, Kauten J, Hartman A, McKay R, Hagberg R, Huang J, Popma J; CoreValve Investigators. Neurological events following transcatheter aortic valve replacement and their predictors: a report from the CoreValve trials. Circulation. Cardiovascular Interventions. 2016;9(9):e003551. https://doi.org/10.1161/CIRCINTERVENTIONS.115.003551
  36. Megaly M, Sorajja P, Cavalcante JL, Pershad A, Gössl M, Abraham B, Omer M, Elbadawi A, Garcia S. Ischemic stroke with cerebral protection system during transcatheter aortic valve replacement. JACC CardioVascular and Interventional Radiology. 2020;13(18):2149-2155. https://doi.org/10.1016/j.jcin.2020.05.039
  37. Nombela-Franco L, Webb JG, de Jaegere PP, Toggweiler S, Nuis RJ, Dager AE, Amat-Santos IJ, Cheung A, Ye J, Binder RK, van der Boon RM, Van Mieghem N, Benitez LM, Pérez S, Lopez J, San Roman JA, Doyle D, Delarochellière R, Urena M, Leipsic J, Dumont E, Rodés-Cabau J. Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation. Circulation. 2012;126: 3041-3053. https://doi.org/10.1161/CIRCULATIONAHA.112.110981
  38. Auffret V, Regueiro A, Del Trigo M, Abdul-Jawad Altisent O, Campelo-Parada F, Chiche O, Puri R, Rodés-Cabau J. Predictors of early cerebrovascular events in patients with aortic stenosis undergoing transcatheter aortic valve replacement. Journal of the American College of Cardiology. 2016;68(7):673-684.  https://doi.org/10.1016/j.jacc.2016.05.065
  39. Thourani VH, O’Brien SM, Kelly JJ, Cohen DJ, Peterson ED, Mack MJ, Shahian DM, Grover FL, Carroll JD, Brennan JM, Forcillo J, Arnold SV, Vemulapalli S, Fitzgerald S, Holmes DR, Bavaria JE, Edwards FH. Development and application of a risk prediction model for in-hospital stroke after transcatheter aortic valve replacement: a report from the society of thoracic Surgeons/American College of Cardiology transcatheter valve Therapy registry. The Annals of Thoracic Surgery. 2019;107(4):1097-1103. https://doi.org/10.1016/j.athoracsur.2018.11.013
  40. Bjursten H, Norrving B, Ragnarsson S. Late stroke after transcatheter aortic valve replacement: a nationwide study. Scientific Reports. 2021;11(1):9593. https://doi.org/10.1038/s41598-021-89217-0
  41. Ghanem A, Müller A, Nähle CP, Kocurek J, Werner N, Hammerstingl C, Schild HH, Schwab JO, Mellert F, Fimmers R, Nickenig G, Thomas D. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. Journal of the American College of Cardiology. 2010;55(14):1427-1432. https://doi.org/10.1016/j.jacc.2009.12.026
  42. Arnold M, Schulz-Heise S, Achenbach S, Ott S, Dörfler A, Ropers D, Feyrer R, Einhaus F, Loders S, Mahmoud F, Roerick O, Daniel WG, Weyand M, Ensminger SM, Ludwig J. Embolic cerebral insults after transapical aortic valve implantation detected by magnetic resonance imaging. JACC. Cardiovascular Interventions. 2010;3(11):1126-1132. https://doi.org/10.1016/jcin.2010.09.008
  43. Kahlert P, Knipp SC, Schlamann M, Thielmann M, Al-Rashid F, Weber M, Johansson U, Wendt D, Jakob HG, Forsting M, Sack S, Erbel R, Eggebrecht H. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation. 2010;121(7):870-878.  https://doi.org/10.1161/CIRCULATIONAHA.109.855866
  44. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. New England Journal of Medicine. 2003;348(13):1215-1222. https://doi.org/10.1056/NEJMoa022066
  45. Lansky AJ, Brown D, Pena C, Pietras CG, Parise H, Ng VG, Meller S, Abrams KJ, Cleman M, Margolis P, Petrossian G, Brickman AM, Voros S, Moses J, Forrest JK. Neurologic complications of unprotected transcatheter aortic valve implantation (from the Neuro-TAVI trial). American Journal of Cardiology. 2016;118(10):1519-1526. https://doi.org/10.1016/j.amjcard.2016.08.013
  46. Ahmad Y, Nijjer S, Cook CM, El-Harasis M, Graby J, Petraco R, Kotecha T, Baker CS, Malik IS, Bellamy MF, Sethi A, Mikhail GW, Al-Bustami M, Khan M, Kaprielian R, Foale RA, Mayet J, Davies JE, Francis DP, Sen S. A new method of applying randomised control study data to the individual patient: a novel quantitative patient-centred approach to interpreting composite end points. International Journal of Cardiology. 2015;195:216-224.  https://doi.org/10.1016/j.ijcard.2015.05.109
  47. Stolker JM, Spertus JA, Cohen DJ, Jones PG, Jain KK, Bamberger E, Lonergan BB, Chan PS. Rethinking composite end points in clinical trials: insights from patients and trialists. Circulation. 2014;130(15):1254-1261. https://doi.org/10.1161/CIRCULATIONAHA.113.006588
  48. Coylewright M, Palmer R, O’Neill ES, Robb JF, Fried TR. Patient-defined goals for the treatment of severe aortic stenosis: a qualitative analysis. Health Expectations. 2016;19(5):1036-1043. https://doi.org/10.1111/hex.12393
  49. Moses JW. Cerebral Embolic Protection During TAVR: Where We Are After TCT? 2020. Accessed November 15, 2024. https://cvinterventions.com/wp-content/uploads/2020/11/Moses-Jeffrey-Cerebral-Protection.pdf
  50. Pagnesi M, Martino EA, Chiarito M, Mangieri A, Jabbour RJ, Van Mieghem NM, Kodali SK, Godino C, Landoni G, Colombo A, Latib A. Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: a systematic review and metaanalysis. International Journal of Cardiology. 2016;221:97-106.  https://doi.org/10.1016/j.ijcard.2016.06.143
  51. Linke A, Haussig S, Dwyer MG, Magner N, Lehmkuhl L, Lucke C, Woitek F, et al. Clean-TAVI: A prospective, randomized trial of cerebral embolic protection in high-risk patients with aortic stenosis undergoing transcatheter arotic valve replacement. 2014:1-23. Accessed November 15, 2024. https://www.sac.org.ar/wp-content/uploads/2014/09/tct-2014-clean-tavi.pdf.
  52. Carroll JD, Mack MJ, Vemulapalli S, Herrmann HC, Gleason TG, Hanzel G, Deeb GM, Thourani VH, Cohen DJ, Desai N, Kirtane AJ, Fitzgerald S, Michaels J, Krohn C, Masoudi FA, Brindis RG, Bavaria JE. STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement. The Annals of Thoracic Surgery. 2021;111(2):701-722.  https://doi.org/10.1016/j.athoracsur.2020.09.002
  53. Isogai T, Bansal A, Vanguru HR, Agrawal A, Shekhar S, Puri R, Reed GW, Krishnaswamy A, Uchino K, Kapadia SR. Cerebral embolic protection and stroke-related mortality following transcatheter aortic valve replacement. JACC. Cardiovascular Interventions. 2022;15(5):569-571.  https://doi.org/10.1016/j.jcin.2022.01.007
  54. Isogai T, Vanguru HR, Krishnaswamy A, Agrawal A, Spilias N, Shekhar S, Saad AM, Verma BR, Puri R, Reed GW, Popović ZB, Unai S, Yun JJ, Uchino K, Kapadia SR. Cerebral embolic protection and severity of stroke following transcatheter aortic valve replacement. Catheterization and Cardiovascular Interventions. 2022;100(5):810-820.  https://doi.org/10.1002/ccd.30340
  55. Giustino G, Mehran R, Veltkamp R, Faggioni M, Baber U, Dangas GD. Neurological outcomes with embolic protection devices in patients undergoing transcatheter aortic valve replacement. JACC. Cardiovascular Interventions. 2016;9:2124-2133. https://doi.org/10.1016/j.jcin.2016.07.024
  56. Ahmad Y, Howard JP. Meta-analysis of usefulness of cerebral embolic protection during transcatheter aortic valve implantation. American Journal of Cardiology. 2021;146:69-73.  https://doi.org/10.1016/j.amjcard.2021.01.023
  57. Kapadia SR, Makkar R, Leon M, Abdel-Wahab M, Waggoner T, Massberg S, Rottbauer W, Horr S, Sondergaard L, Karha J, Gooley R, Satler L, Stoler RC, Messé SR, Baron SJ, Seeger J, Kodali S, Krishnaswamy A, Thourani VH, Harrington K, Pocock S, Modolo R, Allocco DJ, Meredith IT, Linke A; PROTECTED TAVR Investigators. Cerebral embolic protection during transcatheter aortic-valve replacement. New England Journal of Medicine. 2022;387(14):1253-1263. https://doi.org/10.1056/nejmoa2204961
  58. Zahid S, Ullah W, Zia Khan M, Faisal Uddin M, Rai D, Abbas S, Usman Khan M, Hussein A, Salama A, Bandyopadhyay D, Baibhav B, Rao M, Alam M, Alraies MC, Balla S, Alkhouli M, Depta JP. Cerebral Embolic Protection during Transcatheter Aortic Valve Implantation: Updated Systematic Review and Meta-Analysis. Cardiology. 2023;48(6):101-127.  Https://doi.org/10.1016/j.cpcardiol.2022.101127
  59. Butala NM, Makkar R, Secemsky EA, Gallup D, Marquis-Gravel G, Kosinski AS, Vemulapalli S, Valle JA, Bradley SM, Chakravarty T, Yeh RW, Cohen DJ. Cerebral embolic protection and outcomes of transcatheter aortic valve replacement: results from the transcatheter valve Therapy registry. Circulation. 2021;143(23):2229-2240.
  60. Khan MZ, Zahid S, Khan MU, Kichloo A, Ullah W, Sattar Y, Munir MB, Singla A, Goldsweig AM, Balla S. Use and outcomes of cerebral embolic protection for transcatheter aortic valve replacement: a US nationwide study. Catheterization and Cardiovascular Interventions. 2021;98(5):959-968.  https://doi.org/10.1002/ccd.29842
  61. Kharbanda RK, Perkins AD, Kennedy J, Banning AP, Baumbach A, Blackman DJ, Dodd M, et al. Routine cerebral embolic protection in transcatheter aortic valve implantation: rationale and design of the randomised British Heart Foundation PROTECTTAVI trial. EuroIntervention. 2023;18(17):1428-1435. https://doi.org/10.4244/EIJ-D-22-00713
  62. Kharbanda R, Kapadia S. Sentinel protection: A Global Prospective Meta-Analysis of the protected TAVR and BHF PROTECT-TAVI Studies. PROSPERO 2022 CRD42022324160. Accessed November 15, 2024. https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022324160
  63. Корчажкина Н.Б., Михайлова А.А., Ковалев С.А., Портнов В.В., Ржевский В.С. Эффективность методик ранней реабилитации в программах ускоренного выздоровления больных после хирургических вмешательств. Физиотерапия, бальнеология и реабилитация. 2019;18(6):408-411.  https://doi.org/10.17816/1681-3456-2019-18-6-408-411
  64. Корчажкина Н.Б. Третий этап медицинской реабилитации в условиях санаторно-курортных организаций. Дальнейшее развитие санаторно-курортного лечения после оказания специализированной, в том числе высокотехнологичной медицинской помощи. Курортная медицина. 2013;3:69-72. 
  65. Орехова Э.М., Кончугова Т.В., Кульчицкая Д.Б., Корчажкина Н.Б., Егорова Л.А., Чуич Н.Г. Современные подходы к применению трансцеребральной магнитотерапии при артериальной гипертензии. Вопросы курортологии, физиотерапии и лечебной физической культуры. 2016;93(3):53-55.  https://doi.org/10.17116/kurort2016353-55
  66. Aronov M, Shevchenko NS, Amosova NA, Kotenko KV. Acute three-vessel cervical arterial occlusion due to spontaneous quadruple cervical artery dissection. BMJ Case Reports. 2014;2014:bcr2014203725. https://doi.org/10.1136/bcr-2014-203725
  67. База данных научных исследований по применению физических факторов в хирургии. Михайлова А.А., Котенко К.В., Корчажкина Н.Б., Бельская Н.А., Ковалёв С.А., Горягин А.О. Свидетельство о регистрации базы данных RU 2021621978, 16.09.2021. Заявка №2021621880 от 09.09.2021.
  68. Корчажкина Н.Б., Михайлова А.А., Ковалев С.А., Ржевский В.С., Портнов В.В. Обоснование применения метода глубокой осцилляции импульсным низкочастотным электростатическим полем в раннем реабилитационном периоде после оперативных вмешательств. Физиотерапия, бальнеология и реабилитация. 2020;19(4):244-248.  https://doi.org/10.17816/1681-3456-2020-19-4-7

Подтверждение e-mail

На test@yandex.ru отправлено письмо со ссылкой для подтверждения e-mail. Перейдите по ссылке из письма, чтобы завершить регистрацию на сайте.

Подтверждение e-mail

Мы используем файлы cооkies для улучшения работы сайта. Оставаясь на нашем сайте, вы соглашаетесь с условиями использования файлов cооkies. Чтобы ознакомиться с нашими Положениями о конфиденциальности и об использовании файлов cookie, нажмите здесь.